CV Sciences Inc (CVSI)

[Wolf-man jack]

WQLF SAYS: The lower end of the FUTURE R/S is 1:10 Rev 1800. The Super - Voting Preferred Stock is not on the table TALIBAN TROLLER in the upcoming vote. And by the way you would never have been a good Attorney if one tried because the Super Voting Preferred Stock was LEGAL in 2022 YQU Now Understand YQU Understand. Your posts are just NOISE and IRRELEVANT and ALWAYS posting Dis-information as a non shareholder for that matter. The Loan 🦈 s have an advantage at this point. They acquired 9 million voting shares before the deadline. The company is extending their Reverse Split that expired on May 30, 2025. The only difference this time is the 1:800 ratio. There is no need to panic. The new R/S extends for three years
The same time period from the last successful R/S split vote held in 2022. To prove that there are no worries, I will be voting FOR the R/S with my 1,862,780 Voting Shares. If YQU can't Beat them, then why not Join them YQU Now Understand YQU Understand. Rev 1800 clearly understands YQU Understand.


Proposal 3 - Reverse Stock Split

The Company’s stockholders approved the Company's proposal to amend its Charter (as may be amended from time to time) to effect, at the discretion of the Board, a reverse
stock split of all of its issued and outstanding shares of common stock at a ratio of not less than 1-for-10 and not greater than 1-for-400, such ratio to be determined by the
Board at any time before May 30, 2025, without further approval or authorization of the Company's stockholders, as set forth below:

Dr. Joong J Fang SAID

The Preferred shareholders in 2022 were granted 119,000,000 Shares. Without those Shares, the Reverse Split would have still passed, with 40,140,977 FOR and 26,942,274 AGAINST. The difference of 13.2 Million Shares. The major shareholder Clayton Montgomery holds around 15,883,066 shares. The loan sharks converted around 9.18 Million shares. This would give the FOR votes around a 25 Million share advantage, not including the 14 million shares advantage from the 2022 vote.


,Shares Outstanding 193.46M
Implied Shares Outstanding 193.46M
Float
% Held by Insiders 1 8.21%

FOR 159,140,977/ AGAINST 26,942,774/ABSTAIN BROKER NON-VOTES/729,224

As a result, the Company is authorized, subject to Board approval and the approval of the Financial Industry Regulatory Authority, to file an amendment to its Charter to effect
a reverse split in accordance with the terms approved by the Company’s stockholders at the 2022 Annual Meeting at any time prior to May 30, 2025.
https://ir.cvsciences.com/all-sec-filings/content/0001510964-22-000048/0001510964-22-000048.pdf

Rev1800 Said;

I'm ok with a reasonable r/s.... after we have a solid organic move. 1/5 @ 1.00 sounds good to me.

Ai Generated:

Yes, creating or issuing super-voting preferred stock is generally lawful under state corporate laws, such as the Delaware General Corporation Law, which allows companies broad flexibility to define the voting rights, preferences, and powers of different stock classes in their corporate charter.

However, whether they are permitted depends heavily on the company's status and exchange regulations:

Private Companies: Super-voting preferred or common stock is entirely lawful and common. Founders, executives, and early investors use it to maintain voting control while raising capital from outside investors.

Public Companies (Stock Exchange Rules): While still legal under state law, major U.S. stock exchanges generally prohibit newly issuing super-voting preferred stock to avoid diluting or disenfranchising the voting rights of existing public shareholders.

Corporate Governance Rules: Major indices (like the S&P 500) and large institutional investors typically oppose or restrict companies with multi-class, super-voting structures because they concentrate power in the hands of a few insiders.

Ai Generated:

During the 2022 Annual Meeting of CV Sciences, Inc. held on May 26, 2022, the single institutional preferred shareholder holding the 700 outstanding shares of Series A Convertible Preferred Stock was granted a voting ratio of 170,000 votes per preferred share on specific proposals.


This disproportionate voting ratio gave the preferred shareholder an aggregate of 119,000,000 votes, which accounted for approximately 49.37% of the total 241,040,186 possible votes at the meeting.

The preferred stock was not entitled to vote on all matters, but it was granted this specific voting power alongside common stockholders (who held 1 vote per share) to approve an amendment increasing the authorized number of shares and allowing for a reverse stock split. You can review the official corporate filing on the SEC.gov 2022 Annual Meeting 8-K or read more about the offering terms on the SEC.gov March 2022 Securities Purchase Agreement.

Clayton J. Montgomery is the major shareholder of CV Sciences, Inc. (OTCQB: CVSI), holding approximately 8.2% to 8.6% of the company's common stock. His significant ownership stake in the consumer wellness company stems from CV Sciences' acquisition of Elevated Softgels LLC in 2024, of which he was a founding member